These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19896447)

  • 21. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
    McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
    J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.
    Chaintoutis SC; Diakakis N; Papanastassopoulou M; Banos G; Dovas CI
    Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.
    Volz A; Lim S; Kaserer M; Lülf A; Marr L; Jany S; Deeg CA; Pijlman GP; Koraka P; Osterhaus AD; Martina BE; Sutter G
    Vaccine; 2016 Apr; 34(16):1915-26. PubMed ID: 26939903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA reduction of neuronal West Nile virus replication attenuates and affords a protective immune response in mice.
    Brostoff T; Pesavento PA; Barker CM; Kenney JL; Dietrich EA; Duggal NK; Bosco-Lauth AM; Brault AC
    Vaccine; 2016 Oct; 34(44):5366-5375. PubMed ID: 27637937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus.
    Dayan GH; Pugachev K; Bevilacqua J; Lang J; Monath TP
    Viruses; 2013 Dec; 5(12):3048-70. PubMed ID: 24351795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuated West Nile viruses bearing 3'SL and envelope gene substitution mutations.
    Yu L; Robert Putnak J; Pletnev AG; Markoff L
    Vaccine; 2008 Nov; 26(47):5981-8. PubMed ID: 18805457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A DNA-based West Nile virus replicon elicits humoral and cellular immune responses in mice.
    Cao F; Li XF; Yu XD; Deng YQ; Jiang T; Zhu QY; Qin ED; Qin CF
    J Virol Methods; 2011 Dec; 178(1-2):87-93. PubMed ID: 21893098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
    Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S
    Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.
    Magnusson SE; Karlsson KH; Reimer JM; Corbach-Söhle S; Patel S; Richner JM; Nowotny N; Barzon L; Bengtsson KL; Ulbert S; Diamond MS; Stertman L
    Vaccine; 2014 Feb; 32(7):800-8. PubMed ID: 24380682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assurance of neuroattenuation of a live vaccine against West Nile virus: a comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine.
    Maximova OA; Speicher JM; Skinner JR; Murphy BR; St Claire MC; Ragland DR; Herbert RL; Pare DR; Moore RM; Pletnev AG
    Vaccine; 2014 May; 32(26):3187-97. PubMed ID: 24736001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
    Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection.
    Wessel AW; Doyle MP; Engdahl TB; Rodriguez J; Crowe JE; Diamond MS
    mBio; 2021 Oct; 12(5):e0244021. PubMed ID: 34634945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.
    Pletnev AG; Claire MS; Elkins R; Speicher J; Murphy BR; Chanock RM
    Virology; 2003 Sep; 314(1):190-5. PubMed ID: 14517072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutations.
    Schlick P; Kofler RM; Schittl B; Taucher C; Nagy E; Meinke A; Mandl CW
    Vaccine; 2010 Aug; 28(36):5903-9. PubMed ID: 20600500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA vaccines encoding the envelope protein of West Nile virus lineages 1 or 2 administered intramuscularly, via electroporation and with recombinant virus protein induce partial protection in large falcons (Falco spp.).
    Fischer D; Angenvoort J; Ziegler U; Fast C; Maier K; Chabierski S; Eiden M; Ulbert S; Groschup MH; Lierz M
    Vet Res; 2015 Aug; 46(1):87. PubMed ID: 26282836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of antigen-specific immune responses in mice by recombinant baculovirus expressing premembrane and envelope proteins of West Nile virus.
    Zhu B; Ye J; Lu P; Jiang R; Yang X; Fu ZF; Chen H; Cao S
    Virol J; 2012 Jul; 9():132. PubMed ID: 22799608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baboon model for West Nile virus infection and vaccine evaluation.
    Wolf RF; Papin JF; Hines-Boykin R; Chavez-Suarez M; White GL; Sakalian M; Dittmer DP
    Virology; 2006 Nov; 355(1):44-51. PubMed ID: 16904151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine.
    Kitai Y; Kondo T; Konishi E
    J Virol Methods; 2011 Jan; 171(1):123-8. PubMed ID: 20974180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.